2 Stocks to Add to Your Must-Buy List in Q4
After a disappointing third-quarter performance, investors should brace themselves for an enhanced market uncertainty in the fourth quarter amid the Fed’s persistent rate hikes to tame stubborn inflation and growing recession fears. Hence, we think it could be wise to add resilient and dividend-yielding stocks Johnson & Johnson (JNJ) and Merck (MRK) to your portfolio…